US 12083113
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted A61KA61K31/381A61K31/4164
Quick answer
US patent 12083113 (Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients) held by Northwestern University expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/381, A61K31/4164, A61K31/47, A61K31/495